Table 1.
Characteristics of patients with fecal positive and negative SARS-CoV-2 RNA tests.
| Parameters | Patients with positive fecal tests (n = 20) | Patients with negative fecal tests (n = 49) | P value |
|---|---|---|---|
| Age(yr) | 43 (31.25–51.0) | 52 (42–62.5) | 0.003 |
| Sex | |||
| Male |
13 (65 %) | 27 (55.10 %) | 0.45 |
| Female |
7 (35 %) | 22 (44.90 %) | |
| Exposure history | |||
| Stay in Hubei Province | 5 (25 %) | 7 (14.29 %) | 0.287 |
| Contact with people from Hubei Province | 5 (25 %) | 8 (16.31 %) | 0.403 |
| Familial aggregation | 11 (55 %) | 19 (38.78 %) | 0.217 |
| Chronic medical illness | |||
| Diabetes mellitus | 1 (5 %) | 10 (20.4 %) | 0.112 |
| Hypertension |
3 (15 %) | 10 (20.4 %) | 0.602 |
| Treatment Glucocorticoids |
|||
| Glucocorticoids Antibiotics |
1 (5 %) | 10 (20.4 %) | 0.112 |
| Antibiotics |
5 (25 %) | 14 (28.6 %) | 0.763 |
| Arbidol |
16 (80 %) | 39 (79.6 %) | 0.969 |
| Recombinant Human Interferon α2b Spray | 11 (55 %) | 3 (65.3 %) | 0.423 |
| Chloroquine Phosphate | 1 (5 %) | 0 | 0.115 |
Data are presented as interquartile ranges (IQRs), numbers and percentages.